The FDA has granted clearance to Israel-based EarlySense for its improved EverOn Touch patient-monitoring device. The system can track and alert medical providers about a patient's vital signs and movements.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||